These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 21360849)

  • 41. NGF release from poly(D,L-lactide-co-glycolide) microspheres. Effect of some formulation parameters on encapsulated NGF stability.
    Péan JM; Venier-Julienne MC; Boury F; Menei P; Denizot B; Benoit JP
    J Control Release; 1998 Dec; 56(1-3):175-87. PubMed ID: 9801441
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tetanus toxoid microspheres consisting of biodegradable poly(lactide-co-glycolide)- and ABA-triblock-copolymers: immune response in mice.
    Jung T; Koneberg R; Hungerer KD; Kissel T
    Int J Pharm; 2002 Mar; 234(1-2):75-90. PubMed ID: 11839439
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Enhancing initial release of peptide from poly(d,l-lactide-co-glycolide) (PLGA) microspheres by addition of a porosigen and increasing drug load.
    Ravivarapu HB; Lee H; DeLuca PP
    Pharm Dev Technol; 2000; 5(2):287-96. PubMed ID: 10810758
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Development of a novel formulation containing poly(d,l-lactide-co-glycolide) microspheres dispersed in PLGA-PEG-PLGA gel for sustained delivery of ganciclovir.
    Duvvuri S; Janoria KG; Mitra AK
    J Control Release; 2005 Nov; 108(2-3):282-93. PubMed ID: 16229919
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sustained polymeric delivery of gene silencing antisense ODNs, siRNA, DNAzymes and ribozymes: in vitro and in vivo studies.
    Khan A; Benboubetra M; Sayyed PZ; Ng KW; Fox S; Beck G; Benter IF; Akhtar S
    J Drug Target; 2004 Jul; 12(6):393-404. PubMed ID: 15545089
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Instability of bovine insulin in poly(lactide-co-glycolide) (PLGA) microspheres.
    Uchida T; Yagi A; Oda Y; Nakada Y; Goto S
    Chem Pharm Bull (Tokyo); 1996 Jan; 44(1):235-6. PubMed ID: 8582042
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vitro and in vivo characterization of huperzine a loaded microspheres made from end-group uncapped poly(d,l-lactide acid) and poly(d,l-lactide-co-glycolide acid).
    Gao P; Ding P; Xu H; Yuan Z; Chen D; Wei J; Chen D
    Chem Pharm Bull (Tokyo); 2006 Jan; 54(1):89-93. PubMed ID: 16394556
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mechanistic evaluation of the glucose-induced reduction in initial burst release of octreotide acetate from poly(D,L-lactide-co-glycolide) microspheres.
    Wang J; Wang BM; Schwendeman SP
    Biomaterials; 2004 May; 25(10):1919-27. PubMed ID: 14738856
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Preparation of ONO-1301-loaded poly(lactide-co-glycolide) microspheres and their effect on nerve conduction velocity.
    Hazekawa M; Sakai Y; Yoshida M; Haraguchi T; Morisaki T; Uchida T
    J Pharm Pharmacol; 2011 Mar; 63(3):362-8. PubMed ID: 21749383
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development of andrographolide loaded PLGA microspheres: optimization, characterization and in vitro-in vivo correlation.
    Jiang Y; Wang F; Xu H; Liu H; Meng Q; Liu W
    Int J Pharm; 2014 Nov; 475(1-2):475-84. PubMed ID: 25219858
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Importance of the test medium for the release kinetics of a somatostatin analogue from poly(D,L-lactide-co-glycolide) microspheres.
    Blanco-Príeto MJ; Besseghir K; Orsolini P; Heimgartner F; Deuschel C; Merkle HP; Nam-Trân H; Gander B
    Int J Pharm; 1999 Jul; 184(2):243-50. PubMed ID: 10387954
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hydrophilic poly(DL-lactide-co-glycolide) microspheres for the delivery of DNA to human-derived macrophages and dendritic cells.
    Walter E; Dreher D; Kok M; Thiele L; Kiama SG; Gehr P; Merkle HP
    J Control Release; 2001 Sep; 76(1-2):149-68. PubMed ID: 11532321
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Assessment of protein release kinetics, stability and protein polymer interaction of lysozyme encapsulated poly(D,L-lactide-co-glycolide) microspheres.
    Jiang G; Woo BH; Kang F; Singh J; DeLuca PP
    J Control Release; 2002 Feb; 79(1-3):137-45. PubMed ID: 11853925
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vitro and in vivo evaluation of a somatostatin analogue released from PLGA microspheres.
    Blanco-Príeto MJ; Besseghir K; Zerbe O; Andris D; Orsolini P; Heimgartner F; Merkle HP; Gander B
    J Control Release; 2000 Jun; 67(1):19-28. PubMed ID: 10773325
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chitin/PLGA blend microspheres as a biodegradable drug-delivery system: phase-separation, degradation and release behavior.
    Mi FL; Lin YM; Wu YB; Shyu SS; Tsai YH
    Biomaterials; 2002 Aug; 23(15):3257-67. PubMed ID: 12102197
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Importance of single or blended polymer types for controlled in vitro release and plasma levels of a somatostatin analogue entrapped in PLA/PLGA microspheres.
    Blanco-Príeto MJ; Campanero MA; Besseghir K; Heimgatner F; Gander B
    J Control Release; 2004 May; 96(3):437-48. PubMed ID: 15120900
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Biodegradable ibuprofen-loaded PLGA microspheres for intraarticular administration. Effect of Labrafil addition on release in vitro.
    Fernández-Carballido A; Herrero-Vanrell R; Molina-Martínez IT; Pastoriza P
    Int J Pharm; 2004 Jul; 279(1-2):33-41. PubMed ID: 15234792
    [TBL] [Abstract][Full Text] [Related]  

  • 58. PEGylated TNF-related apoptosis-inducing ligand (TRAIL)-loaded sustained release PLGA microspheres for enhanced stability and antitumor activity.
    Kim TH; Jiang HH; Park CW; Youn YS; Lee S; Chen X; Lee KC
    J Control Release; 2011 Feb; 150(1):63-9. PubMed ID: 21062635
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile.
    Rafiei P; Haddadi A
    Int J Nanomedicine; 2017; 12():935-947. PubMed ID: 28184163
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Polymer degradation and in vitro release of a model protein from poly(D,L-lactide-co-glycolide) nano- and microparticles.
    Panyam J; Dali MM; Sahoo SK; Ma W; Chakravarthi SS; Amidon GL; Levy RJ; Labhasetwar V
    J Control Release; 2003 Sep; 92(1-2):173-87. PubMed ID: 14499195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.